Home

Kiválaszt Párolog Sárgaréz bi 2536 könnyű megsérülni Még mindig ingatlan

Characterization of BI 2536-resistant clones (a) Structure of PLK1... |  Download Scientific Diagram
Characterization of BI 2536-resistant clones (a) Structure of PLK1... | Download Scientific Diagram

BI 2536 regulates Plk1 expression and induces cell cycle arrest and... |  Download Scientific Diagram
BI 2536 regulates Plk1 expression and induces cell cycle arrest and... | Download Scientific Diagram

PLK1 inhibitor | BI-2536 | opnMe | Boehringer Ingelheim
PLK1 inhibitor | BI-2536 | opnMe | Boehringer Ingelheim

BI-2536 (CAS Number: 755038-02-9) | Cayman Chemical
BI-2536 (CAS Number: 755038-02-9) | Cayman Chemical

BI 2536 | ≥99%(HPLC) | Selleck | PLK inhibitor
BI 2536 | ≥99%(HPLC) | Selleck | PLK inhibitor

Effect of PLK1 inhibition by BI 2536 on REST protein expression and... |  Download Scientific Diagram
Effect of PLK1 inhibition by BI 2536 on REST protein expression and... | Download Scientific Diagram

BI2536, a potent and selective inhibitor of polo-like kinase 1, in  combination with cisplatin exerts synergistic effects on gastric cancer  cells
BI2536, a potent and selective inhibitor of polo-like kinase 1, in combination with cisplatin exerts synergistic effects on gastric cancer cells

BI 2536 | PLK1 inhibitor | BI2536 | BI-2536 | CAS [755038-02-9] | Axon 1129  | Axon Ligand™ with >99% purity available from stock from supplier Axon  Medchem
BI 2536 | PLK1 inhibitor | BI2536 | BI-2536 | CAS [755038-02-9] | Axon 1129 | Axon Ligand™ with >99% purity available from stock from supplier Axon Medchem

BI-2536 and BI-6727, dual Polo-like kinase/bromodomain inhibitors,  effectively reactivate latent HIV-1 | Scientific Reports
BI-2536 and BI-6727, dual Polo-like kinase/bromodomain inhibitors, effectively reactivate latent HIV-1 | Scientific Reports

Mitotic arrest is required for BI 2536/VCR-induced apoptosis. A. SH-EP... |  Download Scientific Diagram
Mitotic arrest is required for BI 2536/VCR-induced apoptosis. A. SH-EP... | Download Scientific Diagram

PLK1 inhibitor | BI-2536 | opnMe | Boehringer Ingelheim
PLK1 inhibitor | BI-2536 | opnMe | Boehringer Ingelheim

BI 2536 | PLK1 Inhibitor | MedChemExpress
BI 2536 | PLK1 Inhibitor | MedChemExpress

BI 2536, a potent and selective PLK1 inhibitor, disrupts GNS cell... |  Download Scientific Diagram
BI 2536, a potent and selective PLK1 inhibitor, disrupts GNS cell... | Download Scientific Diagram

The Small-Molecule Inhibitor BI 2536 Reveals Novel Insights into Mitotic  Roles of Polo-like Kinase 1 - ScienceDirect
The Small-Molecule Inhibitor BI 2536 Reveals Novel Insights into Mitotic Roles of Polo-like Kinase 1 - ScienceDirect

Effect of AKT3 expression on MYC‐ and caspase‐8‐dependent apoptosis caused  by polo‐like kinase inhibitors in HCT 116 cells - Nonomiya - 2016 - Cancer  Science - Wiley Online Library
Effect of AKT3 expression on MYC‐ and caspase‐8‐dependent apoptosis caused by polo‐like kinase inhibitors in HCT 116 cells - Nonomiya - 2016 - Cancer Science - Wiley Online Library

BI 2536 | PLK1 Inhibitor | MedChemExpress
BI 2536 | PLK1 Inhibitor | MedChemExpress

PLK1 inhibitor | BI-2536 | opnMe | Boehringer Ingelheim
PLK1 inhibitor | BI-2536 | opnMe | Boehringer Ingelheim

BI 2536 | ≥99%(HPLC) | Selleck | PLK inhibitor
BI 2536 | ≥99%(HPLC) | Selleck | PLK inhibitor

BI 2536 | CAS 755038-02-9 | SCBT - Santa Cruz Biotechnology
BI 2536 | CAS 755038-02-9 | SCBT - Santa Cruz Biotechnology

PLK1 inhibitor | BI-2536 | opnMe | Boehringer Ingelheim
PLK1 inhibitor | BI-2536 | opnMe | Boehringer Ingelheim

Inhibition of PLK1 by the drug BI 2536 suppresses in vitro cell... |  Download Scientific Diagram
Inhibition of PLK1 by the drug BI 2536 suppresses in vitro cell... | Download Scientific Diagram

Pharmaceuticals | Free Full-Text | BI-2536 Promotes Neuroblastoma Cell  Death via Minichromosome Maintenance Complex Components 2 and 10
Pharmaceuticals | Free Full-Text | BI-2536 Promotes Neuroblastoma Cell Death via Minichromosome Maintenance Complex Components 2 and 10

BI2536, a potent and selective inhibitor of polo-like kinase 1, in  combination with cisplatin exerts synergistic effects on gastric cancer  cells
BI2536, a potent and selective inhibitor of polo-like kinase 1, in combination with cisplatin exerts synergistic effects on gastric cancer cells

BI 2536 | PLK1 Inhibitor | MedChemExpress
BI 2536 | PLK1 Inhibitor | MedChemExpress